Registration is now open for MD Becker Partners' 3rd annual “Cancer Immunotherapy: A Long Awaited Reality” conference event in New York.  

This unique, single-day conference event unites founding visionary researchers, clinicians, business leaders, key investors, and other stakeholders to engage in discussions, exchange information, highlight opportunities, and showcase leading companies in the field of cancer immunotherapy. It will be held on Thursday, October 4, 2012, at the New York Academy of Medicine. 

JMP Securities, Cantor Fitzgerald and Roth Capital Partners return as event sponsors. 

To register or present, and for more information, please go to the Conference Website. 

See website for complete article licensing information.